Dewpoint partners with Chemify to expedite discovery of molecules
Under the partnership, both firms will develop a range of digitally discovered and automatically synthesised molecules on Chemify's…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Sep 23
Under the partnership, both firms will develop a range of digitally discovered and automatically synthesised molecules on Chemify's…
13 Sep 23
The money raised from the Series B extension will be used by ROME to advance its LINE-1 reverse…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
13 Sep 23
Through the acquisition, the French firm adds VERT-002, a monoclonal antibody that targets and degrades c-MET, which is…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
13 Sep 23
The collaboration aims to expedite the development of an immuno-oncology product designed to treat specific cancers
13 Sep 23
This partnership signifies a monumental step in regenerative medicine, notably in the sectors of active soft tissue repair,…
12 Sep 23
Pfizer and BioNTech’s updated Covid-19 vaccine, Comirnaty 2023-2024, and Moderna’s Spikevax were indicated for people aged 12 years…
12 Sep 23
The CHRYSALIS-2 study cohort evaluated the safety and tolerability of the combination of Rybrevant with Lazertinib plus platinum-based…
12 Sep 23
SB17, a proposed biosimilar to Stelara (Ustekinumab), is Samsung Bioepis’ fourth candidate in the immunology pipeline, after SB4…
12 Sep 23
The partnership aims to pioneer innovative and transformative therapies for cancer patients facing substantial unmet medical needs
12 Sep 23
This transaction provides the Genentech and Roche R&D units with these three components of Herophilus’ discovery platform